Actuate Therapeutics, Inc.
ACTU
$7.35
-$0.08-1.08%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 2.82% | 1.87% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -8.32% | -6.23% | |||
| Operating Income | 8.32% | 6.23% | |||
| Income Before Tax | 9.11% | 5.82% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 9.11% | 5.82% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 9.11% | 5.82% | |||
| EBIT | 8.32% | 6.23% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 16.55% | 6.54% | |||
| Normalized Basic EPS | 16.53% | 6.52% | |||
| EPS Diluted | 16.55% | 6.54% | |||
| Normalized Diluted EPS | 16.53% | 6.52% | |||
| Average Basic Shares Outstanding | 8.90% | 0.76% | |||
| Average Diluted Shares Outstanding | 8.90% | 0.76% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||